Methodology and Applied Biostatistics (MetABio)

At (Methodology and applied biostatistics) MetABio research core, our team are focused to improve scientific evidence of type 1/ type 2 diabetes, obesity, and metabolic disorders incompliance with ethical considerations. According to prevention and control of metabolic disorders, research areas at MetABio are as follows.

Clinical Trials

Through clinical trials, researchers at MetABio core evaluate safety and effectiveness of new treatment and medications for metabolic disorders, and help make it possible for patients to receive new and effective treatments quickly.

Systematic Review & Mata analysis

Our research team are investigating to identify, evaluate, and summarize the findings of all relevant individual studies on metabolic disorders, thereby making the available evidence more accessible to decision makers.

Translational Research

Patient care and research specialists at MetABio research core are committed to translating scientific discoveries and laboratory breakthroughs into patient therapies and a potential cure for metabolic disorders.

Etiology/ Natural History/ Complications

Our investigators at MetABio research core aim to unravel the etiology of metabolic disorders and its complications. The major focus is on the genetic determinants, environmental risk factors, and natural history of the disease processes underlying the development of late metabolic complications.

All activities at MetABio research core are based on transparency to develop reliable evidence in the field of epidemiology of diseases and promotion of the health system. We are committed to implementing universally acceptable models in our research activities that are consistent with global and regional findings. We also strive for scientific and research cooperation with educational and research centers at the national and international levels to develop the evidence needed for effective and fair policies in the health system.